Larry Borish
Overview
Explore the profile of Larry Borish including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
176
Citations
3565
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Borish L
Ann Allergy Asthma Immunol
. 2024 Mar;
132(3):257-258.
PMID: 38432781
No abstract available.
12.
Conway A, White A, Borish L, Shaker M, Lee M
Ann Allergy Asthma Immunol
. 2024 Mar;
133(1):13-15.
PMID: 38432553
No abstract available.
13.
Altamirano C, Breidenbaugh M, Borish L
Ann Allergy Asthma Immunol
. 2023 Dec;
132(1):5-6.
PMID: 38123281
No abstract available.
14.
Noonan E, Suozzi N, Smith A, Lyons C, Borish L, Barnes B, et al.
Dermatitis
. 2023 Nov;
35(4):404-406.
PMID: 38011020
No abstract available.
15.
Spergel J, Borish L, Grayson M, Greenhawt M, Leung D, Levi-Schaffer F, et al.
Ann Allergy Asthma Immunol
. 2023 Oct;
132(2):117-118.
PMID: 37863191
No abstract available.
16.
Borish L
Ann Allergy Asthma Immunol
. 2023 Aug;
131(2):277-278.
PMID: 37536876
No abstract available.
17.
Mehta A, Lee I, Li G, Jones M, Hanson L, Lonabaugh K, et al.
Res Sq
. 2023 May;
PMID: 37215020
Background Treatment of cystic fibrosis (CF) has been revolutionized by the use of cystic fibrosis transmembrane conductance regulator (CFTR) protein modulators such as elexacaftor/tezacaftor/ivacaftor (ETI) triple therapy. Prior studies support...
18.
Noonan E, Straesser M, Makin T, Williams A, Al-Hazaymeh A, Routes J, et al.
J Clin Immunol
. 2023 May;
43(6):1448-1454.
PMID: 37169968
Purpose: Immunoglobulin E deficiency (IgED) (defined as IgE < 2 IU/mL) is enriched in patients with primary antibody deficiency (PAD). We hypothesized that selective IgED (sIgED) is a more sensitive...
19.
Corren J, Jackson D, Casale T, Borish L, Rabe K, Busse W, et al.
J Asthma Allergy
. 2023 Mar;
16:249-260.
PMID: 36915284
Purpose: Dupilumab, a fully human monoclonal antibody, blocks the shared receptor component for interleukins-4/-13, key and central drivers of type 2 (T2) inflammation in multiple diseases. In phase 3 QUEST...
20.
Albon D, Zhang L, Patrie J, Jones M, Li Z, Noonan E, et al.
Allergy Asthma Clin Immunol
. 2023 Feb;
19(1):15.
PMID: 36849900
Background: The Cystic Fibrosis Foundation Patient Registry (CFFPR) reports a high prevalence of asthma (34.6%) in people with Cystic Fibrosis (PwCF). While our current understanding of this relationship is limited,...